The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-1-(4-fluorophenyl)-2-(1H-imidazol-1-yl)ethyl 3-(1H-imidazol-1-yl)propylcarbamate ID: ALA3318311
PubChem CID: 118708811
Max Phase: Preclinical
Molecular Formula: C18H20FN5O2
Molecular Weight: 357.39
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NCCCn1ccnc1)O[C@@H](Cn1ccnc1)c1ccc(F)cc1
Standard InChI: InChI=1S/C18H20FN5O2/c19-16-4-2-15(3-5-16)17(12-24-11-8-21-14-24)26-18(25)22-6-1-9-23-10-7-20-13-23/h2-5,7-8,10-11,13-14,17H,1,6,9,12H2,(H,22,25)/t17-/m0/s1
Standard InChI Key: IAYURHVUHOVFID-KRWDZBQOSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
16.7302 -9.1206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4926 -9.8351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9051 -9.1206 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.9051 -10.5496 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.6676 -9.8351 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.2551 -9.1206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6676 -8.4061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5907 -6.9380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9776 -6.3860 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.2631 -6.7985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4346 -7.6054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2551 -7.6916 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.4301 -9.1206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0176 -9.8351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1926 -9.8351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7801 -9.1206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1926 -8.4061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0176 -8.4061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9551 -9.1206 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
17.1427 -8.4061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9676 -8.4061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3801 -7.6916 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.1991 -7.6010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3707 -6.7940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6562 -6.3815 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.0432 -6.9337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
2 4 2 0
2 5 1 0
1 3 1 0
6 7 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
8 12 1 0
7 12 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
13 18 2 0
16 19 1 0
6 13 1 0
6 5 1 6
1 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 22 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 357.39Molecular Weight (Monoisotopic): 357.1601AlogP: 2.78#Rotatable Bonds: 8Polar Surface Area: 73.97Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.08CX LogP: 1.61CX LogD: 1.48Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.63Np Likeness Score: -1.21
References 1. Friggeri L, Hargrove TY, Rachakonda G, Williams AD, Wawrzak Z, Di Santo R, De Vita D, Waterman MR, Tortorella S, Villalta F, Lepesheva GI.. (2014) Structural basis for rational design of inhibitors targeting Trypanosoma cruzi sterol 14α-demethylase: two regions of the enzyme molecule potentiate its inhibition., 57 (15): [PMID:25033013 ] [10.1021/jm500739f ]